[HTML][HTML] Polymer-free drug-coated coronary stents in patients at high bleeding risk
P Urban, IT Meredith, A Abizaid… - … England Journal of …, 2015 - Mass Medical Soc
Background Patients at high risk for bleeding who undergo percutaneous coronary
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …
[HTML][HTML] Sirolimus-eluting versus uncoated stents in acute myocardial infarction
C Spaulding, P Henry, E Teiger, K Beatt… - … England Journal of …, 2006 - Mass Medical Soc
Background Sirolimus-eluting stents reduce rates of restenosis and reintervention, as
compared with uncoated stents. Data are limited regarding the safety and efficacy of such …
compared with uncoated stents. Data are limited regarding the safety and efficacy of such …
Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
MC Morice, A Colombo, B Meier, P Serruys… - Jama, 2006 - jamanetwork.com
ContextCompared with bare metal stents, sirolimus-eluting and paclitaxel-eluting stents
have been shown to markedly improve angiographic and clinical outcomes after …
have been shown to markedly improve angiographic and clinical outcomes after …
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry
P Urban, AH Gershlick, G Guagliumi, P Guyon… - Circulation, 2006 - Am Heart Assoc
Background—The expanding indications for sirolimus-eluting stents (SES) include
increasingly complex coronary lesions and populations with clinical profiles markedly …
increasingly complex coronary lesions and populations with clinical profiles markedly …
Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing …
M Valgimigli, PW Serruys, K Tsuchida, S Vaina… - The American journal of …, 2007 - Elsevier
The Syntax score (SXscore) was recently developed as a comprehensive angiographic
scoring system aiming to assist in patient selection and risk stratification of patients with …
scoring system aiming to assist in patient selection and risk stratification of patients with …
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo …
Objectives: The purpose of this study is to compare the 5-year clinical outcomes, safety, and
efficacy of sirolimus-eluting stents (SES) in the ARTS II (Arterial Revascularization Therapies …
efficacy of sirolimus-eluting stents (SES) in the ARTS II (Arterial Revascularization Therapies …
A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral …
D Scheinert, K Katsanos, T Zeller… - Journal of the American …, 2012 - jacc.org
Objectives: The study investigated the efficacy and safety of a balloon expandable, sirolimus-
eluting stent (SES) in patients with symptomatic infrapopliteal arterial disease. Background …
eluting stent (SES) in patients with symptomatic infrapopliteal arterial disease. Background …
Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial
MC Morice, PW Serruys, P Barragan, C Bode… - Journal of the American …, 2007 - jacc.org
Objectives: This study examined the clinical outcomes at 5 years in RAVEL (A Randomized
Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary …
Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary …
2-year outcomes of high bleeding risk patients after polymer-free drug-coated stents
P Garot, MC Morice, D Tresukosol, SJ Pocock… - Journal of the American …, 2017 - jacc.org
Background A 1-year follow-up, polymer-free metallic stent coated with biolimus-A9 followed
by 1-month dual antiplatelet therapy is safer and more effective than a bare-metal stent …
by 1-month dual antiplatelet therapy is safer and more effective than a bare-metal stent …
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention …
PW Serruys, K Takahashi, P Chichareon… - European heart …, 2019 - academic.oup.com
Aims To evaluate the impact of an experimental strategy [23-month ticagrelor monotherapy
following 1-month dual antiplatelet therapy (DAPT)] vs. a reference regimen (12-month …
following 1-month dual antiplatelet therapy (DAPT)] vs. a reference regimen (12-month …